| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 05/13/2009 | CN100486608C Coryza-treating capsule and preparation process thereof |
| 05/13/2009 | CN100486607C Health-care food for regulating anemia |
| 05/13/2009 | CN100486606C Total sennoside extract for treating constipation and its extraction process |
| 05/13/2009 | CN100486604C Chinese medicine extract formulation for treating heart incompetence and its process |
| 05/13/2009 | CN100486603C Clathrate containing barrenwort total flavone cyclodextrin or cyclodextrin derivative, preparation and preparing method thereof |
| 05/13/2009 | CN100486598C Bupleurum root asarum herb dripping pill and its preparing method |
| 05/13/2009 | CN100486595C Brazil mushroom soluble small molecular extract, its preparation technology and use |
| 05/13/2009 | CN100486589C Slow release antibiotics preparation of bioactive substance |
| 05/13/2009 | CN100486587C Clarithromycin liposome microsphere injection and its preparation method |
| 05/13/2009 | CN100486585C Antitumor ginsenoside Rh2 injection and its preparation process |
| 05/13/2009 | CN100486583C Diabetin for injection and its preparation process |
| 05/13/2009 | CN100486582C Liniment for treating flat wart |
| 05/13/2009 | CN100486581C Progesterone membrane agent and its preparing method |
| 05/13/2009 | CN100486577C Nimodipine lipid nano particle compositions, and its preparation method |
| 05/13/2009 | CN100486572C Medicament form of tatin class |
| 05/13/2009 | CN100486569C Poly olefinic taxadol self assembled precusor liposome and its preparation method |
| 05/13/2009 | CN100486568C Loxoprofen sodium sustained release preparation |
| 05/13/2009 | CN100486567C Curcumin emulsion and its preparation process |
| 05/13/2009 | CN100486566C New type quick oral disintegration tablet of Subing and preparation method |
| 05/13/2009 | CN100486565C Hawthorm extract fat lowering dispersion tablet and its preparation technology |
| 05/13/2009 | CN100486564C Jinkui kidney qi fast dispersion solid preparation and its preparation method |
| 05/13/2009 | CN100486563C Medicine composition for treating upper respiratory tract infection and its preparation process |
| 05/13/2009 | CN100486562C Medicine composition for treating coronary heart disease and its preparation process and use |
| 05/13/2009 | CN100486561C Manufacturing technique of freeze-dried wilsonii powder for injection |
| 05/13/2009 | CN100486560C Slow released compound anticancer injection containing blood vessel inhibitor |
| 05/13/2009 | CN100486456C Health-care food used for reliefing eyestrain, and its preparing method |
| 05/12/2009 | US7531604 Phospholipid derivative containing a polyoxyalkylene group comprising two or more kinds of alkylene oxides, as well as a surfactant, solubilizer, dispersing agent; for cosmetics and lipid membrane structures; drug delivery of antitumor agents |
| 05/12/2009 | US7531562 Compositions and methods for protecting cells during cancer chemotherapy and radiotherapy |
| 05/12/2009 | US7531520 Drug and food or drink for improving pancreatic functions |
| 05/12/2009 | US7531516 Antiinflammatory agents; multiple sclerosis; inflamamtory bowel disorders; antitumor agents; sepsis |
| 05/12/2009 | US7531500 Preventing airway mucus production by administration of EGF-R antagonists |
| 05/12/2009 | US7531499 Spermine to facilitate absorption of cilostazol, rebamipide, cyclosporin and nifedipine |
| 05/12/2009 | US7531346 comprising cell residues obtained by removing internal soluble components from enzyme-treated yeast, or cell residues obtained by treating the cell residues with acid solution and removing the acid solution-soluble components, used as coatings |
| 05/12/2009 | US7531334 emulsion polymerization of monomers, oligomers or polymer species to form monodisperse microstructure latex particles, then modifying the particles with functional groups capable of binding proteins, carbohydrates and/or haptens, |
| 05/12/2009 | US7531192 prevents solvent glycerol separating from oral gel drug components by mixing with a blend comprising carbohydrates, hydrocolloids, sugars, sugar alcohols or sugar syrups; injection molding a gel drug forms of nutritional supplyment |
| 05/12/2009 | US7531191 Stimuli-responsive systems for controlled drug delivery |
| 05/12/2009 | US7531190 Porous ceramic structure containing biologics |
| 05/12/2009 | US7531184 Aluminum hydroxide on powdery substrate |
| 05/12/2009 | US7531182 Vaccine against foot-and-mouth disease |
| 05/12/2009 | CA2548078C Pharmaceutical formulations of camptothecins and process for making same |
| 05/12/2009 | CA2518102C Powdery preparation for nasal administration |
| 05/12/2009 | CA2513344C Modified electrodes and their use |
| 05/12/2009 | CA2484494C High dose ibandronate formulation |
| 05/12/2009 | CA2478237C Use of adapalene for the treatment of dermatological disorders |
| 05/12/2009 | CA2416869C Vaccines |
| 05/12/2009 | CA2412561C Highly efficient delivery of a large therapeutic mass aerosol |
| 05/12/2009 | CA2387398C Novel combination of loteprednol and antihistamines |
| 05/12/2009 | CA2386404C Method of treating inflammatory conditions with progesterone or progesterone analogs |
| 05/12/2009 | CA2384301C Sustained-release drug formulations for implantation |
| 05/12/2009 | CA2377301C Controlled release and taste masking oral pharmaceutical compositions |
| 05/12/2009 | CA2377299C Mesalazine controlled release oral pharmaceutical compositions |
| 05/12/2009 | CA2356080C Improved formulation for transportation of corticosteroid through pores of a barrier |
| 05/12/2009 | CA2348842C Muco-adhesive polymers, use thereof and method for producing the same |
| 05/12/2009 | CA2347744C Polymerizable material and sheet material derived therefrom |
| 05/12/2009 | CA2341973C Antioxidant composition comprising acetyl l-carnitine and .alpha.-lipoic acid |
| 05/12/2009 | CA2201940C Method of treating diabetes mellitus using kgf |
| 05/12/2009 | CA2136492C Pharmaceutical composition containing diclofenac and 2-hydroxypropyl-.beta.-cyclodextrin |
| 05/11/2009 | CA2705453A1 Pharmaceutical compositions |
| 05/08/2009 | CA2643290A1 Adhesive skin patch sheet |
| 05/07/2009 | WO2009059219A2 Method of engineering polar drug particles with surface-trapped hydrofluoroalkane-philes |
| 05/07/2009 | WO2009059191A1 Compositions and methods for treatment of ear canal infection and inflammation |
| 05/07/2009 | WO2009059120A2 Injectable meclizine formulations and methods |
| 05/07/2009 | WO2009058950A2 Pharmaceutical formulations comprising telmisartan and hydrochlorothiazide |
| 05/07/2009 | WO2009058798A2 Orally disintegrated dosage form |
| 05/07/2009 | WO2009058585A2 Non-aqueous water-miscible materials as vehicles for drug delivery |
| 05/07/2009 | WO2009058147A1 Loadable polymeric particles for therapeutic use in erectile dysfunction |
| 05/07/2009 | WO2009058136A1 An orally-absorbed solid dose formulation for vancomycin |
| 05/07/2009 | WO2009058135A1 Loadable polymeric microparticles for therapeutic use in alopecia and methods of preparing and using the same |
| 05/07/2009 | WO2009058005A2 Unit dosage for brain health |
| 05/07/2009 | WO2009057994A1 Unit dosage for brain health |
| 05/07/2009 | WO2009057975A2 Pharmaceutical composition for the prevention and treatment of cell proliferative diseases comprising of the feathers of birds as the active ingredient |
| 05/07/2009 | WO2009057808A1 Poorly soluble substance-surfactant complex product, and process for production thereof |
| 05/07/2009 | WO2009057787A1 Silica nanocapsule |
| 05/07/2009 | WO2009057785A1 Process for producing medicinal preparation packed with drug instable to heat |
| 05/07/2009 | WO2009057672A1 Method for stabilization of iodophor-containing solid preparation |
| 05/07/2009 | WO2009057569A1 Film-coated preparation |
| 05/07/2009 | WO2009057456A1 Gel sheet and cosmetic preparation in sheet form using the same |
| 05/07/2009 | WO2009057138A2 Controlled release pharmaceutical compositions of tolterodine |
| 05/07/2009 | WO2009056980A1 Stabilized pediatric suspension of carisbamate |
| 05/07/2009 | WO2009056851A1 Compositions for treating parkinson's disease |
| 05/07/2009 | WO2009056703A1 Flavoured clay-based therapeutic composition |
| 05/07/2009 | WO2009056651A1 Angiotensin-carrier formulation |
| 05/07/2009 | WO2009056603A1 Capsule for receiving pharmaceutical active ingredient formulations |
| 05/07/2009 | WO2009056569A1 Lh liquid formulations |
| 05/07/2009 | WO2009056550A2 Bupropion hydrobromide and therapeutic applications |
| 05/07/2009 | WO2009056522A1 Topical composition |
| 05/07/2009 | WO2009056266A2 Candesartan cilexetil |
| 05/07/2009 | WO2009056247A1 Composition comprising polyunsaturated fatty acids and activated charcoal |
| 05/07/2009 | WO2009056212A1 Compositions containing resveratrol and pectin |
| 05/07/2009 | WO2009055923A1 Ingestible film composition |
| 05/07/2009 | WO2009055860A1 Transdermal delivery system |
| 05/07/2009 | WO2009055859A1 Transdermal delivery system for hormones and steroids |
| 05/07/2009 | WO2009055846A1 Improved tablet coating |
| 05/07/2009 | WO2009039262A3 Steroid containing ophthalmic drug delivery systems |
| 05/07/2009 | WO2009039157A3 Orlistat pharmaceutical formulations |
| 05/07/2009 | WO2009036712A3 Dosage form containing tramadol with controlled 24-hour release and a process for manufacturing the same |
| 05/07/2009 | WO2009035265A3 Calcium phosphate microspheres drug delivery system and process for preparing the same |
| 05/07/2009 | WO2009032266A3 Dispersions of microparticles and microgels in hydrogels for drug delivery |
| 05/07/2009 | WO2009031896A3 Improved liposomes and uses thereof |
| 05/07/2009 | WO2009031819A3 Composition for prevention or treatment of bone metabolism disorder comprising d-pinitol as an active ingredient |